Study of Nilotinib in Metastatic Melanoma With KIT Aberrations

NCT01099514 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center